南方医院策划:铿锵三人行——ESC热点速递
2022-08-26 14:00:00~2022-09-03 18:00:00
![](https://statics.drvoice.cn/statics/images/drvoice/favor.png)
介绍
日程安排
2022 ESC Guidelines
17:15-18:15  线上直播
时间
题目
讲者
17:15-18:15
2022年ESC室性心律失常患者管理及预防心源性猝死指南
2022 ESC Guidelines on ventricular arrhythmias and sudden cardiac death
![](https://statics.drvoice.cn/statics/images/drvoice/play.png)
![](https://statics.drvoice.cn/statics/images/drvoice/like.png)
![](https://statics.drvoice.cn/statics/images/drvoice/favor.png)
林海若, 黄晓波, 张秋霞
HOT LINE SESSION 1
20:00-21:05  线上直播
时间
题目
讲者
20:00-20:17
TIME – 早晨治疗vs.晚上治疗研究
TIME - The Treatment in Morning versus Evening study.
![](https://statics.drvoice.cn/statics/images/drvoice/play.png)
![](https://statics.drvoice.cn/statics/images/drvoice/like.png)
![](https://statics.drvoice.cn/statics/images/drvoice/favor.png)
吴爵非, 周忠江, 张秋霞
20:24-20:40
二级预防中的复方制剂策略:SECURE试验的结果
A polypill strategy in secondary prevention: results of the SECURE trial
![](https://statics.drvoice.cn/statics/images/drvoice/play.png)
![](https://statics.drvoice.cn/statics/images/drvoice/like.png)
![](https://statics.drvoice.cn/statics/images/drvoice/favor.png)
何利伟, 黄兴福, 张秋霞
20:48-21:05
PERSPECTIVE - HFmrEF和HFpEF患者中沙库巴曲缬沙坦与认知功能
PERSPECTIVE - Sacubitril/valsartan and cognitive function in HFmrEF and HFpEF
![](https://statics.drvoice.cn/statics/images/drvoice/play.png)
![](https://statics.drvoice.cn/statics/images/drvoice/like.png)
![](https://statics.drvoice.cn/statics/images/drvoice/favor.png)
陈妍梅, 宾建平, 张秋霞
HOT LINE SESSION 2
14:30-15:49  线上直播
时间
题目
讲者
14:30-14:47
DANCAVAS -通过筛查和干预手段预防心血管疾病
DANCAVAS - Screening and intervention to prevent cardiovascular disease.
![](https://statics.drvoice.cn/statics/images/drvoice/play.png)
![](https://statics.drvoice.cn/statics/images/drvoice/like.png)
![](https://statics.drvoice.cn/statics/images/drvoice/favor.png)
林海若, 廖禹林, 张建琴
14:51-15:08
ADVOR - 乙酰唑胺治疗急性心力衰竭
ADVOR - Acetazolamide in acute heart failure.
![](https://statics.drvoice.cn/statics/images/drvoice/play.png)
![](https://statics.drvoice.cn/statics/images/drvoice/like.png)
![](https://statics.drvoice.cn/statics/images/drvoice/favor.png)
刘丹, 曹世平, 张建琴
15:12-15:29
DANFLU-1 - 大剂量vs.标准剂量四价流感疫苗在老年人中的应用
DANFLU-1 - High-dose vs. standard-dose quadrivalent influenza vaccine in elderly adults.
![](https://statics.drvoice.cn/statics/images/drvoice/like.png)
![](https://statics.drvoice.cn/statics/images/drvoice/favor.png)
待定
15:33-15:38
BOX - 氧疗在昏迷院外心跳骤停的患者中的应用
BOX - Oxygen therapy in comatose OHCA patients.
![](https://statics.drvoice.cn/statics/images/drvoice/play.png)
![](https://statics.drvoice.cn/statics/images/drvoice/like.png)
![](https://statics.drvoice.cn/statics/images/drvoice/favor.png)
黄驰雄, 曹世平, 刘丹
15:39-15:49
BOX - 在复苏后的护理中优化血压管理
BOX - Optimizing blood pressure in post-resuscitation care
![](https://statics.drvoice.cn/statics/images/drvoice/like.png)
![](https://statics.drvoice.cn/statics/images/drvoice/favor.png)
待定
TAVI20年
16:30-17:54  线上直播
时间
题目
讲者
16:30-16:42
TAVI:目前的各类风险的相关证据
TAVI: current evidence across the spectrum of risk
![](https://statics.drvoice.cn/statics/images/drvoice/play.png)
![](https://statics.drvoice.cn/statics/images/drvoice/like.png)
![](https://statics.drvoice.cn/statics/images/drvoice/favor.png)
修建成, 宾建平, 韩渊
16:42-16:54
TAVI:证据的空白和适应症扩大
TAVI: gaps in evidence and expanding indications.
![](https://statics.drvoice.cn/statics/images/drvoice/play.png)
![](https://statics.drvoice.cn/statics/images/drvoice/like.png)
![](https://statics.drvoice.cn/statics/images/drvoice/favor.png)
修建成, 吴平生, 韩渊
16:54-17:06
二叶主动脉瓣:确定TAVI的作用
Bicuspid aortic valve: defining the role for TAVI
![](https://statics.drvoice.cn/statics/images/drvoice/play.png)
![](https://statics.drvoice.cn/statics/images/drvoice/like.png)
![](https://statics.drvoice.cn/statics/images/drvoice/favor.png)
王世飞, 曾庆春, 韩渊
17:06-17:18
生物瓣膜衰败的瓣中瓣TAVI:如何处理患者的生命周期中的一次、二次和多次再干预
Valve-in-valve TAVI for bioprosthetic valve failure: how to approach first, second and multiple reinterventions in the lifetime management of patients
![](https://statics.drvoice.cn/statics/images/drvoice/play.png)
![](https://statics.drvoice.cn/statics/images/drvoice/like.png)
![](https://statics.drvoice.cn/statics/images/drvoice/favor.png)
修建成, 侯玉清, 韩渊
17:18-17:30
TAVI期间的脑保护:标准处理
Cerebral embolic protection during TAVI: standard of care
![](https://statics.drvoice.cn/statics/images/drvoice/play.png)
![](https://statics.drvoice.cn/statics/images/drvoice/like.png)
![](https://statics.drvoice.cn/statics/images/drvoice/favor.png)
王世飞, 曾庆春, 韩渊
17:30-17:42
极简TAVI和快速出院流程:未来的处理标准
Minimalist TAVI and rapid discharge protocols: the future standard of care?
![](https://statics.drvoice.cn/statics/images/drvoice/play.png)
![](https://statics.drvoice.cn/statics/images/drvoice/like.png)
![](https://statics.drvoice.cn/statics/images/drvoice/favor.png)
韩渊, 陈国军, 刘季晨
17:42-17:54
讨论:TAVI发展20年后,目前的技术水平如何?
discussion:After 20 years of TAVI: what is the state of the art?
![](https://statics.drvoice.cn/statics/images/drvoice/like.png)
![](https://statics.drvoice.cn/statics/images/drvoice/favor.png)
陈国军, 崔凯, 韩渊
2022 ESC Guidelines
17:15-18:15  线上直播
时间
题目
讲者
17:15-18:15
2022 ESC心脏肿瘤指南
2022 ESC Guidelines on cardio-oncology
![](https://statics.drvoice.cn/statics/images/drvoice/play.png)
![](https://statics.drvoice.cn/statics/images/drvoice/like.png)
![](https://statics.drvoice.cn/statics/images/drvoice/favor.png)
周忠江, 侯玉清, 张建琴
HOT LINE SESSION 3
20:00-21:05  线上直播
时间
题目
讲者
20:00-20:17
REVIVED - 经皮血运重建治疗缺血性心室功能障碍
REVIVED - Percutaneous Revascularisation for Ischaemic Ventricular Dysfunction.
![](https://statics.drvoice.cn/statics/images/drvoice/play.png)
![](https://statics.drvoice.cn/statics/images/drvoice/like.png)
![](https://statics.drvoice.cn/statics/images/drvoice/favor.png)
黄驰雄, 陈国军, 张建琴
20:24-20:40
ALL-HEART - 别嘌呤醇与缺血性心脏病的心血管结局
ALL-HEART - Allopurinol and cardiovascular outcomes in ischaemic heart disease.
![](https://statics.drvoice.cn/statics/images/drvoice/play.png)
![](https://statics.drvoice.cn/statics/images/drvoice/like.png)
![](https://statics.drvoice.cn/statics/images/drvoice/favor.png)
张秋霞, 周忠江, 张建琴
20:48-21:05
EchoNet-RCT – 人工智能指导下的左心室射血分数测量的安全性和有效性研究
EchoNet-RCT - Safety and Efficacy Study of AI LVEF
![](https://statics.drvoice.cn/statics/images/drvoice/play.png)
![](https://statics.drvoice.cn/statics/images/drvoice/like.png)
![](https://statics.drvoice.cn/statics/images/drvoice/favor.png)
吴爵非, 吴平生, 张建琴
HOT LINE SESSION 4
22:30-23:25  线上直播
时间
题目
讲者
22:30-22:50
DELIVER - 达格列净在射血分数轻度降低和射血分数保留的心力衰竭中的应用
DELIVER - Dapagliflozin in Heart Failure with Mildly Reduced and Preserved Ejection Fraction.
![](https://statics.drvoice.cn/statics/images/drvoice/play.png)
![](https://statics.drvoice.cn/statics/images/drvoice/like.png)
![](https://statics.drvoice.cn/statics/images/drvoice/favor.png)
陈妍梅, 廖禹林, 王世飞
22:55-23:05
DAPA-HF研究和DELIVER研究的汇总分析
Pooled analysis of DAPA-HF and DELIVER
![](https://statics.drvoice.cn/statics/images/drvoice/play.png)
![](https://statics.drvoice.cn/statics/images/drvoice/like.png)
![](https://statics.drvoice.cn/statics/images/drvoice/favor.png)
詹琼, 曾庆春, 王世飞
23:10-23:25
一项预先设定的DELIVER研究和EMPEROR-Preserved研究的荟萃分析
A Pre-Specified Meta-Analysis of DELIVER and EMPEROR-Preserved
![](https://statics.drvoice.cn/statics/images/drvoice/play.png)
![](https://statics.drvoice.cn/statics/images/drvoice/like.png)
![](https://statics.drvoice.cn/statics/images/drvoice/favor.png)
詹琼, 曾庆春, 王世飞
HOT LINE SESSION 5
14:30-15:53  线上直播
时间
题目
讲者
14:30-14:47
INVICTUS - 利伐沙班与维生素K拮抗剂治疗风湿性房颤的对比
INVICTUS - Rivaroxaban versus VKA for rheumatic atrial fibrillation
![](https://statics.drvoice.cn/statics/images/drvoice/play.png)
![](https://statics.drvoice.cn/statics/images/drvoice/like.png)
![](https://statics.drvoice.cn/statics/images/drvoice/favor.png)
王月刚, 曹世平, 刘丹
14:52-15:09
PACIFIC-AMI - 急性心肌梗死后双联抗血小板治疗的基础上应用XIa因子抑制剂Asundexian的有效性和安全性
PACIFIC-AMI - Efficacy and safety of factor XIa inhibitor asundexian on top of dual antiplatelet therapy after acute myocardial infarction
![](https://statics.drvoice.cn/statics/images/drvoice/play.png)
![](https://statics.drvoice.cn/statics/images/drvoice/like.png)
![](https://statics.drvoice.cn/statics/images/drvoice/favor.png)
吴爵非, 谢晋国, 王世飞
15:14-15:31
PACIFIC-STROKE - 口服复方BAY 2433334抑制XIa因子的抗凝治疗的2期研究 – 非心源性STROKE研究
PACIFIC-STROKE - Phase 2 Program of AntiCoagulation via Inhibition of FXIa by the oral Compound BAY 2433334 – non-cardioembolic STROKE study
![](https://statics.drvoice.cn/statics/images/drvoice/play.png)
![](https://statics.drvoice.cn/statics/images/drvoice/like.png)
![](https://statics.drvoice.cn/statics/images/drvoice/favor.png)
王月刚, 周忠江, 刘丹
15:36-15:53
AXIOMATIC-SSP: 卒中二级预防中XIa因子抑制剂的抗栓治疗优化急性血栓栓塞事件的管理
AXIOMATIC-SSP: Antithrombotic treatment with factor XIa inhibition to Optimize Management of Acute Thromboembolic events for Secondary Stroke Prevention
![](https://statics.drvoice.cn/statics/images/drvoice/play.png)
![](https://statics.drvoice.cn/statics/images/drvoice/like.png)
![](https://statics.drvoice.cn/statics/images/drvoice/favor.png)
王月刚, 吴平生, 刘丹
2022 ESC Guidelines
17:15-18:15  线上直播
时间
题目
讲者
17:15-18:15
2022年ESC-ERS肺动脉高压的诊断和治疗指南
2022 ESC-ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
![](https://statics.drvoice.cn/statics/images/drvoice/play.png)
![](https://statics.drvoice.cn/statics/images/drvoice/like.png)
![](https://statics.drvoice.cn/statics/images/drvoice/favor.png)
陈妍梅, 宾建平, 王世飞
HOT LINE SESSION 6
20:00-21:07  线上直播
时间
题目
讲者
20:00-20:17
eBRAVE-AF - 基于智能手机的房颤筛查
eBRAVE-AF - Smartphone-based AF screening
![](https://statics.drvoice.cn/statics/images/drvoice/play.png)
![](https://statics.drvoice.cn/statics/images/drvoice/like.png)
![](https://statics.drvoice.cn/statics/images/drvoice/favor.png)
李新忠, 王月刚, 张建琴
20:25-20:42
基于因果的人工智能大大提高了评估心血管风险和获益的有效性
Causal AI substantially improves the validity of estimating cardiovascular risk and benefit
![](https://statics.drvoice.cn/statics/images/drvoice/like.png)
![](https://statics.drvoice.cn/statics/images/drvoice/favor.png)
张秋霞, 修建成, 张建琴
20:50-21:07
经人工智能增强的主动脉狭窄的检测
AI-ENHANCED detection of Aortic Stenosis
![](https://statics.drvoice.cn/statics/images/drvoice/play.png)
![](https://statics.drvoice.cn/statics/images/drvoice/like.png)
![](https://statics.drvoice.cn/statics/images/drvoice/favor.png)
韩渊, 修建成, 张秋霞
HOT LINE SESSION 7
22:30-23:27  线上直播
时间
题目
讲者
22:30-22:47
DanNICAD-2 - 冠状动脉造影阳性患者用MR或PET进行灌注扫描
DanNICAD-2 - Perfusion scanning with MR or PET after a positive CT coronary angiography.
![](https://statics.drvoice.cn/statics/images/drvoice/play.png)
![](https://statics.drvoice.cn/statics/images/drvoice/like.png)
![](https://statics.drvoice.cn/statics/images/drvoice/favor.png)
吴爵非, 刘伊丽, 张秋霞
22:50-23:07
The PRE18FFIR 试验: 冠状动脉斑块活动性预测复发不良事件
The PRE18FFIR Trial: Coronary Plaque Activity to Predict Recurrent Events.
![](https://statics.drvoice.cn/statics/images/drvoice/play.png)
![](https://statics.drvoice.cn/statics/images/drvoice/like.png)
![](https://statics.drvoice.cn/statics/images/drvoice/favor.png)
林立龙, 郑华, 刘季晨
23:10-23:27
The FRAME-AMI 试验 – FFR vs.血管造影指导的PCI治疗AMI合并多支血管病变
The FRAME-AMI trial - FFR vs. Angiography-guided PCI in AMI with multivessel disease
![](https://statics.drvoice.cn/statics/images/drvoice/play.png)
![](https://statics.drvoice.cn/statics/images/drvoice/like.png)
![](https://statics.drvoice.cn/statics/images/drvoice/favor.png)
林立龙, 郑华, 刘季晨
HOT LINE SESSION 8
14:30-15:57  线上直播
时间
题目
讲者
14:30-14:45
ISCHEMIA-CKD EXTEND - 5年随访的临床结果(ISCHEMIA试验中针对肾功能不全患者的亚组人群研究)
ISCHEMIA-CKD EXTEND - Clinical Outcomes at 5 years of Follow-up
![](https://statics.drvoice.cn/statics/images/drvoice/play.png)
![](https://statics.drvoice.cn/statics/images/drvoice/like.png)
![](https://statics.drvoice.cn/statics/images/drvoice/favor.png)
吴爵非, 周忠江, 刘季晨
14:48-15:03
MASTER DAPT试验的15个月结果(高出血风险PCI患者的抗血小板治疗)
15-month results of the MASTER DAPT trial
![](https://statics.drvoice.cn/statics/images/drvoice/play.png)
![](https://statics.drvoice.cn/statics/images/drvoice/like.png)
![](https://statics.drvoice.cn/statics/images/drvoice/favor.png)
韩渊, 宾建平, 刘季晨
15:06-15:21
FOURIER-OLE: 主要结果(PCSK9抑制剂相关的FOURIER研究的开放标签扩展研究)
FOURIER-OLE: Primary Results
![](https://statics.drvoice.cn/statics/images/drvoice/play.png)
![](https://statics.drvoice.cn/statics/images/drvoice/like.png)
![](https://statics.drvoice.cn/statics/images/drvoice/favor.png)
陈妍梅, 谢晋国, 刘季晨
15:24-15:39
FIDELITY: 死亡原因(非奈利酮在CKD合并T2D患者中的应用)
FIDELITY: Causes of mortality
![](https://statics.drvoice.cn/statics/images/drvoice/play.png)
![](https://statics.drvoice.cn/statics/images/drvoice/like.png)
![](https://statics.drvoice.cn/statics/images/drvoice/favor.png)
刘季晨, 廖禹林, 王世飞
15:42-15:57
PARADISE-MI试验 - 胜率分析(AMI后心衰高危患者中早期应用ARNI较ACEI在降低心力衰竭事件和心血管死亡复合终点事件的有效性)
PARADISE-MI Trial - Win Ratio Analysis.
![](https://statics.drvoice.cn/statics/images/drvoice/play.png)
![](https://statics.drvoice.cn/statics/images/drvoice/like.png)
![](https://statics.drvoice.cn/statics/images/drvoice/favor.png)
刘季晨, 廖禹林, 王世飞
2022 ESC Guidelines
17:15-18:15  线上直播
时间
题目
讲者
17:15-18:15
2022年ESC非心脏外科手术患者心血管评估和管理指南
2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery
![](https://statics.drvoice.cn/statics/images/drvoice/play.png)
![](https://statics.drvoice.cn/statics/images/drvoice/like.png)
![](https://statics.drvoice.cn/statics/images/drvoice/favor.png)
黄森林, 黄兴福, 王世飞
HOT LINE SESSION 9
20:00-21:09  线上直播
时间
题目
讲者
20:00-20:15
他汀类药物对肌肉症状影响的CTT荟萃分析
CTT meta-analysis of the effects of statins on muscle symptoms
![](https://statics.drvoice.cn/statics/images/drvoice/play.png)
![](https://statics.drvoice.cn/statics/images/drvoice/like.png)
![](https://statics.drvoice.cn/statics/images/drvoice/favor.png)
张建琴, 侯玉清, 刘丹
20:18-20:33
MTT - 评估ARB和β-受体阻滞剂在马凡氏综合征中的作用
MTT - Assessing the effects of ARBs and beta-blockers in Marfan Syndrome
![](https://statics.drvoice.cn/statics/images/drvoice/play.png)
![](https://statics.drvoice.cn/statics/images/drvoice/like.png)
![](https://statics.drvoice.cn/statics/images/drvoice/favor.png)
王前程, 廖禹林, 刘丹
20:36-20:51
PANTHER - P2Y12抑制剂与阿司匹林单药治疗冠心病患者的对比
PANTHER - P2Y12 inhibitor versus aspirin monotherapy in patients with coronary artery disease
![](https://statics.drvoice.cn/statics/images/drvoice/play.png)
![](https://statics.drvoice.cn/statics/images/drvoice/like.png)
![](https://statics.drvoice.cn/statics/images/drvoice/favor.png)
王前程, 周忠江, 张秋霞
20:54-21:09
RTC - 冠状动脉手术中桡动脉vs.股动脉入路
RTC - Radial versus femoral access for coronary procedures
![](https://statics.drvoice.cn/statics/images/drvoice/play.png)
![](https://statics.drvoice.cn/statics/images/drvoice/like.png)
![](https://statics.drvoice.cn/statics/images/drvoice/favor.png)
梁鸿彬, 修建成, 张秋霞